Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

INNOVHEM

Financiado

Cerrado

Innovative diagnostic tools to improve the medical care and the health of Sickle...

Innovative diagnostic tools to improve the medical care and the health of Sickle Cell patients : preparing for launch and market access in Europe INNOVHEM is a french start-up that has been incorporated in October 2019 which develops new and relevant diagnostic tools to tackle Sickle cell disease. Sickle Cell Disease is a very severe disease and is the most frequent genetic... ver más

31/01/2023

INNOVHEM

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

INNOVHEM No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-01-31

HORIZON-EIE-2021-SCALEUP-01-03: Women TechEU ExpectedOutcome:

Innovación

Cerrada hace 3 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INNOVHEM

75.00K€ | Lider

Proyectos interesantes

Symptoma

Medical Technol...

Data Science

2M€ Cerrado

INVESTIGACIÓN Y DESARROLLO DE NUEVAS TECNOLOG...

Medical Technol...

Data Science

445K€ Cerrado

NIMSB

Medical Technol...

Data Science

15M€ Cerrado

ARISE

Medical Technol...

Data Science

2M€ Cerrado

PREDICTOM

Medical Technol...

Data Science

18M€ Cerrado

TED2021-132296A-C53

Medical Technol...

Data Science

133K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 8 meses Fecha Inicio: 2022-05-16
Fecha Fin: 2023-01-31

Líder del proyecto

INNOVHEM No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 75K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto INNOVHEM is a french start-up that has been incorporated in October 2019 which develops new and relevant diagnostic tools to tackle Sickle cell disease. Sickle Cell Disease is a very severe disease and is the most frequent genetic disease over the world, affecting around 5 million people. Despite this disease has been discovered at the beginning of the 20th century, there is still several unmet needs to tackle it. In resource-poor countries, about 90% of children are estimated to die before the age of 5. In Europe, more than 60 000 people are affected. Their life expectency is shortened to around 45 years old and 80% of physicians say that they lack support tools for treatment decision. In addition, SCD is associated to high clinical costs. At INNOVHEM, we are developing a solution which is a combination of biomarkers, specifically adapted to the physiopathology of the disease, with articial intelligence. This solution will help the physicians to propose a personalized medical care to the patients and it will also help the development of new effective treatments. This will deeply improve health of Sickle cell patients. As an example of impacts, one of the short-term goals is to avoid 20% of emergency visits, this sole effect will save $ 30 million / year in Europe. During the first year of activity, INNOVHEM showed a high commercial traction, that allows to sign contracts for a total amonut of 800k euros . We also enter into several partnerships with leading clinical and university centers for sickle cell disease. Our mission is to improve clinical care of Sickle cell patients and improve their lives. A financial support will help us to build our access market strategy and our growth in Europe.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores